FDA warns about safety risks of tailored weight-loss drugs
The U.S. Food and Drug Administration (FDA) warned about the safety risks of using compounded or custom-made versions of popular weight-loss drugs such as Wegovy and diabetes drug Ozempic. The health regulator on Wednesday said it had received reports of adverse events after patients used compounded versions of semaglutide, the active ingredient in Danish drugmaker […]
The post FDA warns about safety risks of tailored weight-loss drugs appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.